Neoplasm by Special Category — Trials

Neoplasm by Special Category — Trials · CancerIndex

Clinical trials

Registered studies

95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 9,518 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04584255	Niraparib + Dostarlimab In BRCA Mutated Breast Cancer	active not recruiting	Phase 2	66	Dana-Farber Cancer InstituteOTHER	1	Sep 24, 2026	clinicaltrials
NCT04590326	A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab	recruiting	Phase 1 / Phase 2	612	Regeneron PharmaceuticalsINDUSTRY	5	Sep 24, 2026	clinicaltrials